Western blotting analysis showed that p‐Akt and p‐S6 protein expression was down‐regulated in ESCC cells treated with TCN‐P or apatinib, and apatinib enhanced the effect of Akt pathway inhibitor (Figure 5B). Here, AKT1 is linked to esophageal squamous cell carcinoma.